# A Randomized Controlled Trial of Lamivudine in Acute Hepatitis B

> **NCT00380614** · PHASE4 · COMPLETED · sponsor: **Maulana Azad Medical College**

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT00380614
- **Lead sponsor:** Maulana Azad Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** 2005-03
- **Target enrollment:** — (—)
- **Last updated:** 2006-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380614, "A Randomized Controlled Trial of Lamivudine in Acute Hepatitis B". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00380614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
